Disclosures for "Predicting Amyloid-beta Positivity in Cognitively Intact Adults Using Multi-contrast Three-dimensional MRI and Deep Learning"
-
Dr. Saidi has or had stock in Eli Lilly.Dr. Saidi has or had stock in Viking Therapeutics.Dr. Saidi has or had stock in MD Life.Dr. Saidi has or had stock in ProKidney. An immediate family member of Dr. Saidi has or had stock in Viking Therapeutics. An immediate family member of Dr. Saidi has or had stock in MD Life.Dr. Saidi has or had stock in Madrigal Pharmaceuticals. An immediate family member of Dr. Saidi has or had stock in Madrigal Pharmaceuticals.
-
Gina Dumkrieger has received personal compensation for serving as an employee of Mayo Clinic. The institution of Gina Dumkrieger has received research support from NIH. The institution of Gina Dumkrieger has received research support from DOD. The institution of Gina Dumkrieger has received research support from AMGEN.
-
Dr. Cramer has nothing to disclose.
-
Dr. Zhou has nothing to disclose.
-
The institution of Dr. Woodruff has received research support from National Institute on Aging.
-
The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
-
Dr. Baxter has nothing to disclose.
-
Dr. Dumitrascu has nothing to disclose.